Related Experiment Video

Updated: Jun 13, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.7K

Exploring the full potential of Pyrotinib in HER2-positive metastatic breast cancer

Wei-Zhen Tang1, Kang-Jin Huang1, Tai-Hang Liu1

  • 1Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China.

Neoplasia (New York, N.Y.)
|May 21, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K

Related Experiment Videos

Last Updated: Jun 13, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.7K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions.

Drug design, development and therapy·2026

Effect of Common Bile Duct Opening Versus Ligation on Postoperative Outcomes in Patients Undergoing Pancreaticoduodenectomy.

Journal of investigative surgery : the official journal of the Academy of Surgical Research·2026

Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects.

International journal of nanomedicine·2026

The impact of frailty and its changes on the development of motoric cognitive risk syndrome in middle-aged and older adults.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026

Association between adverse obstetric history and perinatal outcomes in singleton and twin pregnancies: a retrospective study.

Frontiers in medicine·2026

Extracellular vesicles in atopic dermatitis: unraveling pathogenic mediators and engineering therapeutic vectors.

Frontiers in immunology·2026

Tumor-specific super-enhancer drives overexpression of EVI1/MECOM in ovarian cancer.

Neoplasia (New York, N.Y.)·2026

An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma.

Neoplasia (New York, N.Y.)·2026

Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers.

Neoplasia (New York, N.Y.)·2026

RSPO1-LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway.

Neoplasia (New York, N.Y.)·2026

Senescence-associated prostate cancer cells promote fibroblast reprogramming and extracellular matrix remodeling.

Neoplasia (New York, N.Y.)·2026

STAT5A-RNF8 signaling regulates homologous recombination repair and cisplatin responsiveness in cervical cancer.

Neoplasia (New York, N.Y.)·2026

Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.

Frontiers in cell and developmental biology·2026

Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?

Frontiers in pharmacology·2026

Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents.

Frontiers in oncology·2026

Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies.

Frontiers in immunology·2026

Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.

Frontiers in immunology·2026

Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us